Home Newsfeeds Twitter Fired More Than 90% of India Staff

Twitter Fired More Than 90% of India Staff

-Bloomberg https://www.bloomberg.com/news/articles/2022-11-07/twitter-fires-more-than-90-of-india-staff-leaving-just-a-dozen?leadSource=uverify%20wall

byCharles Gross

November 7, 2022

1 minute read

-Bloomberg

https://www.bloomberg.com/news/articles/2022-11-07/twitter-fires-more-than-90-of-india-staff-leaving-just-a-dozen?leadSource=uverify%20wall

Stellantis Plans To Build Two More Hybrid Vehicles In Italy Amid Political Tensions: Report

By Benzinga Neuro

May 27, 9:41 AM

The initiative is part of Stellantis's strategy to increase its vehicle production in Italy to 1 million units by 2030, up from approximately 750,000 last year.

STLA

23andMe Therapeutics Present Preliminary Phase 2 Safety And Efficacy Results For 23ME-00610, Targeting CD200R1, At The 2024 ASCO Annual Meeting

By Benzinga Newsdesk

June 3, 8:21 AM

– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME-00610 monotherapy continues to demonstrate acceptable safety and tolerability, and

MGM Resorts International Q1 Earnings Highlights: Revenue And EPS Beat, Record Las Vegas EBITDAR, China Comes Back And BetMGM Update

By Chris Katje

May 1, 4:58 PM

Casino resort operator and sports betting company MGM Resorts International (NYSE: MGM) reported first-quarter financial results after the market close Monday. Here are the key highlights.

MGM

News

Synopsys Advances Designs On TSMC N3E Process With Production-Proven EDA Flows And Broadest IP Portfolio For AI, Mobile And HPC Applications

By Benzinga Newsdesk

October 24, 10:06 AM

Multiple Successful Tapeouts from Leading Companies Demonstrate Robustness of Synopsys Solutions for a Faster Path to Silicon Success MOUNTAIN VIEW, Calif., Oct. 24, 2022 /PRNewswire/ -- Building on a

SNPS

Twitter Fired More Than 90% of India Staff

Related Posts

Stellantis Plans To Build Two More Hybrid Vehicles In Italy Amid Political Tensions: Report

23andMe Therapeutics Present Preliminary Phase 2 Safety And Efficacy Results For 23ME-00610, Targeting CD200R1, At The 2024 ASCO Annual Meeting

MGM Resorts International Q1 Earnings Highlights: Revenue And EPS Beat, Record Las Vegas EBITDAR, China Comes Back And BetMGM Update

Synopsys Advances Designs On TSMC N3E Process With Production-Proven EDA Flows And Broadest IP Portfolio For AI, Mobile And HPC Applications